Rchr
J-GLOBAL ID：202101002527770811
Update date: Sep. 24, 2024
Ninomiya Kiichiro
ニノミヤ キイチロウ | Ninomiya Kiichiro
Affiliation and department：
Job title：
Assistant Professor
Research keywords (4)：
ゲノム医療
, 肺癌
, システマティックレビュー
, 医学統計
Research theme for competitive and other funds (3)：
- 2022 - 2024 腫瘍浸潤リンパ球に基づくがん免疫療法(抗CTLA-4抗体)のバイオマーカー開発
- 2019 - 2022 Development of innovative HER2-targeted therapy in HER2-mutant lung cancer
- 2014 - 2018 Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations
Papers (85)：
-
Taichi Ozeki, Hisao Higo, Hiroki Omori, Shunta Mori, Shin Tanaka, Go Makimoto, Kiichiro Ninomiya, Akihiko Taniguchi, Masanori Fujii, Kentaro Miyoshi, et al. A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension. Internal medicine (Tokyo, Japan). 2024
-
Kiichiro Ninomiya, Daisuke Ennishi, Kunio Okamoto, Midori Ando, Satoko Nakamura, Shuta Tomida, Yoshiyuki Ayada, Go Makimoto, Eiki Ichihara, Natsuko Okita, et al. Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report. JCO precision oncology. 2024. 8. e2400228
-
Hiroaki Matsuura, Hisao Higo, Tadahiro Kuribayashi, Akihiko Tamaoki, Takamasa Nakasuka, Mari Uno, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, et al. Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report. Thoracic cancer. 2024. 15. 17. 1390-1394
-
Tadahiro Kuribayashi, Kadoaki Ohashi, Kazuya Nishii, Kiichiro Ninomiya, Yukari Tsubata, Nobuhisa Ishikawa, Masahiro Kodani, Nobuhiro Kanaji, Masahiro Yamasaki, Kazunori Fujitaka, et al. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study. Journal of cancer research and clinical oncology. 2024. 150. 2. 89-89
-
Yusuke Okuma, Shogo Nomura, Jun Sakakibara-Konishi, Yoko Tsukita, Shuji Murakami, Yukio Hosomi, Yuichi Tambo, Yoshihito Kogure, Hiroshige Yoshioka, Motohiro Tamiya, et al. Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas. Clinical lung cancer. 2024
ｍore...
MISC (121)：
-
中田英二, 藤原智洋, 国定俊之, 遠西大輔, 二宮貴一朗, 冨田秀太, 二川摩周, 山本英喜, 平沢晃, 田端雅弘, et al. ゲノム情報を有効に活用するための診療体制の構築. 日本整形外科学会雑誌. 2023. 97. 6
-
森田智視, 寺岡俊輔, 大矢由子, 森瀬昌宏, 二宮貴一朗, 阪本智宏, 田中謙太郎, 三浦理. サブグループ解析は臨床を変えうるのか?~肺癌学会サブグループ解析検討委員会報告~. 日本呼吸器学会誌(Web). 2023. 12
-
Yuka Kato, Taku Noumi, Kazuhiko Saeki, Kiichiro Ninomiya, Toshio Kubo, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, Masahiro Tabata, et al. Impact on second-line treatment after failure of immune checkpoint inhibitor (ICI) combination chemotherapy in extensive-disease small cell lung cancer: Experience of the Okayama Lung Cancer Study Group. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
-
二宮 貴一朗. 肺癌診療ガイドラインにおける臨床諸問題 ガイドラインに採用されるサブグループ解析とは?. 日本呼吸器学会誌. 2021. 10. 増刊. 31-31
-
Yuichi Takiguchi, Takashi Seto, Kaname Nosaki, Kazuo Hasegawa, Satoshi Morita, Ryo Morita, Kiichiro Ninomiya, Toyoaki Hida. The 2020 edition of the clinical guidelines for lung cancer: Challenges and future perspectives. Japanese Journal of Lung Cancer. 2021. 61. 3. 163-170
ｍore...
Books (9)：
-
Respiratory Syndrome, 3rd Edition V
Nippon Rinsho 2021
-
新臨床腫瘍学 : がん薬物療法専門医のために
南江堂 2021 ISBN:9784524227396
-
肺癌診療ガイドライン : 悪性胸膜中皮腫・胸腺腫瘍含む
金原出版 2021 ISBN:9784307204194
-
肺がん化学療法副作用マネジメント
メジカルビュー社 2019 ISBN:9784758318051
-
肺癌診療ガイドライン : 悪性胸膜中皮腫・胸腺腫瘍含む
金原出版 2018 ISBN:9784307203913
ｍore...
Education (2)：
- 2014 - 2018 Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2003 - 2009 Okayama University Medical School Faculty of Medicine
Professional career (1)：
- Doctor of Philosophy (Okayama University)
Work history (6)：
Committee career (4)：
- 2021/02 - 現在 Japanese Society of Medical Oncology Member of Cancer Immunotherapy Guidelines Committee
- 2018/07 - 現在 日本肺癌学会 中国・四国支部 評議員
- 2015/05 - 現在 Japanese Lung Cancer Society Guideline Committee Member of JLCS
- 2021/04 - 2023/03 高齢者がん診療ガイドライン作成委員会 運営委員
Return to Previous Page
